【24h】

Infection outcomes in splenectomized patients with hemoglobinopathies in Australia.

机译:在澳大利亚,脾切除后有血红蛋白病的患者的感染结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To assess the infection risk of splenectomized persons with hemoglobinopathies in Australia. METHODS: This was an Australia cohort study of infections and vaccinations in 63 patients with hemoglobinopathies followed longitudinally from 1967 to 2006, and an investigation into the risk factors for poor outcome. RESULTS: There were 28 cases of bacterial infection that necessitated hospitalization in the cohort, resulting in an incidence of 1.4 bacterial infections per 100 patient-years. There was one death (1.6%) as a direct result of bacterial infection. Hepatitis C was diagnosed in 28 patients (44%). The spectrum of infection included pneumonia (6/28), cellulitis (6/28), bacteremia (4/28), and skin abscess (3/28). Notably, Klebsiella species organisms were isolated in 9/28 cultures. CONCLUSIONS: Infectious complications in this group of patients cause serious morbidity and mortality. This cohort may be a target for novel preventive strategies such as more immunogenic vaccines, patient registries, and/or education programs.
机译:目的:评估在澳大利亚被脾切除的血红蛋白病患者的感染风险。方法:这是一项澳大利亚队列研究,从1967年至2006年纵向随访了63例血红蛋白病患者的感染和疫苗接种,并调查了预后不良的危险因素。结果:该队列中有28例细菌感染需要住院治疗,每100个患者-年发生1.4细菌感染。细菌感染的直接结果是死亡(1.6%)。丙型肝炎被诊断出28例(44%)。感染范围包括肺炎(6/28),蜂窝组织炎(6/28),菌血症(4/28)和皮肤脓肿(3/28)。值得注意的是,克雷伯菌属生物是在9/28培养物中分离得到的。结论:该组患者的感染并发症导致严重的发病率和死亡率。该人群可能是新型预防策略的目标,例如更多的免疫原性疫苗,患者注册表和/或教育计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号